Koninklijke Philips N.V.
OTCPK:RYLPF
Netherlands / Healthcare / Healthcare Equipment & Supplies
Exchange Data
Hide this widget
Price
25.41 USD
Day change
-0.14 (-0.55%)
52-week range
19.80 - 32.03
Summary of Koninklijke Philips N.V.
Hide this widget
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates throug...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
- (-)
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| RYLP.F | Peers | Sector | |
|---|---|---|---|
Market Cap | 23.859 B | 13.25 B | 65.396 M |
Price % of 52 Week High | - | 87.8% | 62.3% |
Dividend Yield | 0.0% | 1.8% | 0.0% |
Shareholder Yield | 2.1% | 0.6% | -0.7% |
1 Year Price Total Return | 26.1% | 3.2% | -11.0% |
Beta (5 Year) | 0.80 | 0.80 | 0.64 |
In the News
Hide this widget
No data available
Fair Value
Hide this widget
Average
17.09
Downside
-32.8%
Uncertainty
MED
Spread
17.09 - 17.09
Market Range
52 weeks
$20
$32
$25.41
Analyst Targets
0 analysts
-
Investing Models
$17.09
Financial Health
Health Details
Hide this widget
Financial Health for Koninklijke Philips is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Good Performance
▼
▼
Financial Models for Koninklijke Philips N.V.
Model Gallery
Hide this widget
| DuPont ROE AnalysisView Updated 4 days ago |
| Earnings Power ValueView Updated 1 day ago |
| 10Y Historical FinancialsView Updated 4 days ago |
| 5Y Historical FinancialsView Updated 4 days ago |
| CAPM WACC ModelView Updated 9 hours ago |
| P/E MultiplesView Updated 4 days ago |
Historical Financials
Full Financials
Hide this widget
| (USD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 19,089 | 20,059 | 18,669 | 5,588 | 5,225 |
| Operating Income | (200) | 460 | 973 | 614 | 631 |
| Net Profit | (1,722) | (514) | (727) | 43 | (347) |
| Diluted EPS | -1.82 | -0.53 | -0.94 | 0.048 | -0.37 |
| EBITDA | 950 | 1,244 | 1,651 | 810 | 801 |
| Balance Sheet | |||||
| Cash & ST Invest. | 1,267 | 2,067 | 2,489 | 2,067 | 2,489 |
| Current Assets | 10,985 | 10,974 | 10,382 | 10,974 | 10,382 |
| Total Assets | 32,860 | 32,464 | 30,018 | 32,464 | 30,018 |
| Current Liabilities | 8,496 | 9,149 | 8,439 | 9,149 | 8,439 |
| Total Liabilities | 18,637 | 19,149 | 17,542 | 19,149 | 17,542 |
| Total Equity | 14,223 | 13,315 | 12,476 | 13,315 | 12,476 |
| Total Debt | 8,781 | 8,489 | 7,914 | 8,489 | 7,914 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (198) | 2,494 | 1,612 | ||
| Cash From Investing | (1,592) | (702) | (594) | ||
| Cash From Financing | 535 | (936) | (514) | ||
| Free Cash Flow | (674) | 2,113 | 1,284 | 0.00 | - |
Analyst Notes
March 28, 2025
Hide this widget